logo

For the Inventor, By the Inventor

Villeneuve le Roi, France

Jean-Claude Aloup

This inventor holds 23 USPTO granted patents, primarily in Heterocyclic Compounds. Top assignees: Rhone-Poulenc Rorer S.a., Rhone-Poulenc Sante, Aventis Pharma S.a.. Active years: 1981-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Claude Aloup. Retrieved from https://idiyas.com/inventor/jean-claude-aloup

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23

% Patents Active = 87.0

Average Co-Inventor Count = 5.4

ph-index = 4

Forward Citations = 54(Granted Patents)


Company Filing History:

goldMedal13 out of 247 
 
Rhone-Poulenc Rorer S.a.
 patents
silverMedal5 out of 192 
 
Rhone-Poulenc Sante
 patents
bronzeMedal3 out of 377 
 
Aventis Pharma S.a.
 patents
4. 1 out of 81 
 
May & Baker, Ltd.
 patents
5. 1 out of 521 
 
Rhone-Poulenc Industries
 patents

Years Active: 1981-2004

Loading Chart...
Areas of Expertise:
Heterocyclic Compounds
Thiazolobenzoheterocycles
Imidazo Derivatives
Medicaments
Pharmaceuticals
Preparation Methods
Spiro Compounds
N-alkyl Derivatives
Pyrazine Derivatives
Thioformamide Derivatives
Pyridin-3yl Compounds
Tetrahydrothiophene
23 patents (USPTO):Explore Patents
1. 6713468 - Methods of using thiazolobenzoheterocycles (2004-03-30),
2. 6448241 - Thiazolobenzoheterocycles, their preparation and medicaments containing them (2002-09-10),
3. 6423715 - Thiazolobenzoheterocycles, their preparation and medicaments containing them (2002-07-23),
4. 6288075 - Thiazolo[5,4,3-ij]quinolines, preparation and medicines containing the same (2001-09-11),
5. 6100264 - 5H, 10H-imidazo [1,2-A] indeno [1,2-E] pyrazin-4-one derivatives, their (2000-08-08),
6. 6057454 - 1-oxo-1H-inden-2-yl-1H-imidazole-2-carboxylic acid intermediates (2000-05-02),
7. 5990108 - 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one derivatives, (1999-11-23),
8. 5922716 - 5H-indeno�1,2-b!pyrazine-2,3-dione derivatives, their preparation and (1999-07-13),
9. 5902803 - 5H,10H-imidazo�1,2-a!indeno�1,2-e!pyrazin-4-one derivatives, preparation (1999-05-11),
10. 5807859 - Imidazo (1,2-A)-Indeno (1,2-E) pyrazin-4-one derivatives and (1998-09-15),
11. 5789406 - Indeno�1,2-E!pyrazine-4-ones, their preparation and the medicaments (1998-08-04),
12. 5777114 - Spiro�heterocycle-imidazo�1,2-a!indeno�1,2-e!pyrazine!-4'-ones, (1998-07-07),
13. 5753657 - Imidazo�1,2-A! pyrazine-4-one, preparation thereof and drugs containing (1998-05-19),
14. 5726175 - Imidazo�1,2-A!indeno�1,2-E!pyrazine-2-carboxylic acid derivatives, (1998-03-10),
15. 5677306 - Derivatives of 5H, 10H-imidazo�1, 2-a!indeno�1,2-e!pyrazin-4-one, (1997-10-14),

Title: The Innovations of Jean-Claude Aloup: A Patent Pioneer

Introduction: Jean-Claude Aloup, a distinguished inventor based in Villeneuve le Roi, France, has made significant contributions to the field of pharmacology and medicinal chemistry. With an impressive portfolio of 23 patents, Aloup is recognized for his innovative research and development in the synthesis of complex chemical compounds.

Latest Patents: Among his latest patented inventions are the methods of using thiazolobenzoheterocycles, and the development of these compounds along with medicaments containing them. His work in this area has opened new avenues for drug development and therapeutic applications.

Career Highlights: Aloup's career has been marked by his tenure at reputable firms in the pharmaceutical industry. He worked at Rhone-Poulenc Rorer S.A. and Rhone-Poulenc Santé, wherein he advanced his expertise in drug development and chemical engineering. His practical experience in these organizations has played a crucial role in his inventive journey.

Collaborations: Throughout his career, Aloup has collaborated with notable colleagues, including Serge Mignani and Dominique Damour. These partnerships have fostered a creative environment that has led to groundbreaking research and innovative solutions in medicinal chemistry.

Conclusion: Jean-Claude Aloup's contributions to the field have not only resulted in a wealth of patents but have also significantly impacted the pharmaceutical landscape. His continuous innovation and collaboration exemplify the spirit of advancement in science and technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…